Skip to content
10-Q

Quarterly Report

THIRD HARMONIC BIO, INC.

0000950170-25-066412

← back to feed
Filed
May 8, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 45.13M sh
Shares Diluted Q1 2025 · Mar 31, 2025 44.92M sh
Shares Diluted Q1 2025 · Mar 31, 2024 40.21M sh
Capex Q1 2025 · Mar 31, 2025 $0
Capex Q1 2025 · Mar 31, 2024 $0
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$13.48M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$6.29M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $271.61M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $285.06M
Stockholders Equity Q1 2025 · Mar 31, 2025 $272.62M
Stockholders Equity Q1 2025 · Dec 31, 2024 $285.15M
Stockholders Equity Q1 2025 · Mar 31, 2024 $263.5M
Stockholders Equity Q1 2025 · Dec 31, 2023 $269.09M
Current Liabilities Q1 2025 · Mar 31, 2025 $5.1M
Current Liabilities Q1 2025 · Dec 31, 2024 $7.11M
Total Liabilities Q1 2025 · Mar 31, 2025 $7.22M
Total Liabilities Q1 2025 · Dec 31, 2024 $9.46M
Current Assets Q1 2025 · Mar 31, 2025 $276M
Current Assets Q1 2025 · Dec 31, 2024 $290.54M
Total Assets Q1 2025 · Mar 31, 2025 $279.84M
Total Assets Q1 2025 · Dec 31, 2024 $294.61M
Eps Diluted Q1 2025 · Mar 31, 2025 $0.35
Eps Diluted Q1 2025 · Mar 31, 2024 $0.20
Eps Basic Q1 2025 · Mar 31, 2025 $0.35
Eps Basic Q1 2025 · Mar 31, 2024 $0.20
Sga Expense Q1 2025 · Mar 31, 2025 $8.07M
Sga Expense Q1 2025 · Mar 31, 2024 $5.06M
Rd Expense Q1 2025 · Mar 31, 2025 $10.65M
Rd Expense Q1 2025 · Mar 31, 2024 $6.23M
Net Income Q1 2025 · Mar 31, 2025 −$15.83M
Net Income Q1 2025 · Mar 31, 2024 −$7.86M
Operating Income Q1 2025 · Mar 31, 2025 −$18.72M
Operating Income Q1 2025 · Mar 31, 2024 −$11.29M